RSCI (Redwood Scientific Technologies) Debt-to-Asset : 0.00 (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Redwood Scientific Technologies Debt-to-Asset?

Redwood Scientific Technologies RSCI Debt-to-Asset is 0.00 as of Dec. 2023.

Redwood Scientific Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Redwood Scientific Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Redwood Scientific Technologies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $0.30 Mil. Redwood Scientific Technologies's debt to asset for the quarter that ended in Dec. 2023 was 0.00.


Redwood Scientific Technologies  (OTCPK:RSCI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Redwood Scientific Technologies Debt-to-Asset Related Terms


Redwood Scientific Technologies Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies Debt-to-Asset Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
0.00 0.00 0.00 0.00

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Debt-to-Asset 0.00 0.00 0.00 0.00

RSCI vs RAPH, FLGC, TXMD: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redwood Scientific Technologies Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Debt-to-Asset falls into.



Redwood Scientific Technologies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Redwood Scientific Technologies's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Redwood Scientific Technologies's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Redwood Scientific Technologies (RSCI) has a Debt-to-Asset of 0.00 as of Dec. 2023. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' Debt-to-Asset too high?
Redwood Scientific Technologies' current Debt-to-Asset is 0.00.
How does Redwood Scientific Technologies' Debt-to-Asset compare to RAPH and FLGC?
Redwood Scientific Technologies' Debt-to-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Redwood Scientific Technologies and its competitors. Redwood Scientific Technologies's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current Debt-to-Asset is 0.00 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.